The Role of Thromboprophylaxis in Patients with Portal Vein Thrombosis: A Life-Threatening Complication after Laparoscopic Sleeve Gastrectomy Following 8 Years of Experience in a Bariatric Center of Excellence.
Daniela Godoroja-DiartoCatalin CopaescuElena RusuAlina ConstantinPublished in: Diagnostics (Basel, Switzerland) (2022)
Porto-mesenteric vein thrombosis (PVMT) is a rare but life-threatening complication after laparoscopic sleeve gastrectomy (LSG). Laparoscopic sleeve gastrectomy (LSG) is considered the most common procedure for efficiently realizing weight loss and treating obesity-related co-morbidities. This study aimed to shed light on this relatively rare complication by presenting a series of patients who developed PMVT after LSG in light of the need to change the specific protocol of thromboprophylaxis in bariatric patients. We proposed to answer two questions: whether we should perform a thrombophilia workup as a standard practice and whether we should extend chemoprophylaxis to more than 3 weeks among all bariatric patients. This study also aimed to investigate the possible risk factors and eventually present our updated protocol for PMVT management and prophylaxis.
Keyphrases
- weight loss
- end stage renal disease
- roux en y gastric bypass
- bariatric surgery
- risk factors
- chronic kidney disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- gastric bypass
- pulmonary embolism
- peritoneal dialysis
- venous thromboembolism
- type diabetes
- insulin resistance
- body mass index
- skeletal muscle
- direct oral anticoagulants
- quality improvement
- atrial fibrillation
- case report
- drug induced
- gestational age
- high fat diet induced